Cited 37 times in
Sirolimus-versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박시훈 | - |
dc.contributor.author | 양주영 | - |
dc.contributor.author | 이상학 | - |
dc.contributor.author | 장양수 | - |
dc.contributor.author | 고영국 | - |
dc.contributor.author | 권혁문 | - |
dc.contributor.author | 김병옥 | - |
dc.date.accessioned | 2015-08-26T16:36:32Z | - |
dc.date.available | 2015-08-26T16:36:32Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0008-6312 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/114782 | - |
dc.description.abstract | We performed this study in order to compare the immediate and mid-term outcomes of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in lesions of the unprotected left main coronary artery (LMCA). We assessed 54 patients from 5 centers who had undergone unprotected LMCA stenting (35 SES and 19 PES). The procedural success rates were 100 and 95%, respectively, in the SES and PES patients (p = 0.19). At the 6-month clinical follow-up, the event-free probability was 100% in the SES group, and 88% in the PES group (p = 0.07). At the 6-month angiographic follow-up (n = 24), the SES group exhibited a slightly lower late loss than did the PES group (0.24 ± 0.44 vs. 0.65 ± 0.60 mm, p = 0.09), and the restenosis rates were 8 and 9% (p = 0.94) in the SES and PES patients, respectively. In conclusion, both groups exhibited excellent in-hospital and 6-month outcomes with no significant differences between them. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | CARDIOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Antineoplastic Agents, Phytogenic/therapeutic use* | - |
dc.subject.MESH | Blood Vessel Prosthesis Implantation | - |
dc.subject.MESH | Coated Materials, Biocompatible/therapeutic use* | - |
dc.subject.MESH | Coronary Angiography | - |
dc.subject.MESH | Coronary Restenosis/diagnostic imaging | - |
dc.subject.MESH | Coronary Restenosis/etiology | - |
dc.subject.MESH | Coronary Stenosis/diagnostic imaging | - |
dc.subject.MESH | Coronary Stenosis/therapy* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunosuppressive Agents/therapeutic use* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Paclitaxel/therapeutic use* | - |
dc.subject.MESH | Sirolimus/therapeutic use* | - |
dc.subject.MESH | Stents* | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Ventricular Dysfunction, Left/diagnostic imaging | - |
dc.subject.MESH | Ventricular Dysfunction, Left/therapy | - |
dc.title | Sirolimus-versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anatomy (해부학) | - |
dc.contributor.googleauthor | Yang J.Y. | - |
dc.contributor.googleauthor | Lee S.H. | - |
dc.contributor.googleauthor | Ryu S.-K. | - |
dc.contributor.googleauthor | Jeon D.W. | - |
dc.contributor.googleauthor | Kim B.O. | - |
dc.contributor.googleauthor | Park S.H. | - |
dc.contributor.googleauthor | Yoon J.H. | - |
dc.contributor.googleauthor | Lee S.-H. | - |
dc.contributor.googleauthor | Kwon H.M. | - |
dc.contributor.googleauthor | Jang Y. | - |
dc.contributor.googleauthor | Ko Y.-G. | - |
dc.identifier.doi | 10.1159/000088106 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A03509 | - |
dc.contributor.localId | A01555 | - |
dc.contributor.localId | A02320 | - |
dc.contributor.localId | A03448 | - |
dc.contributor.localId | A00127 | - |
dc.contributor.localId | A00260 | - |
dc.contributor.localId | A00501 | - |
dc.contributor.localId | A02833 | - |
dc.relation.journalcode | J00457 | - |
dc.identifier.eissn | 1421-9751 | - |
dc.identifier.pmid | 16155390 | - |
dc.identifier.url | http://www.karger.com/Article/FullText/88106 | - |
dc.subject.keyword | Sirolimus | - |
dc.subject.keyword | Paclitaxel | - |
dc.subject.keyword | Stents | - |
dc.subject.keyword | Coronary stenosis | - |
dc.contributor.alternativeName | Jeon, Dong Woon | - |
dc.contributor.alternativeName | Park, S. H. | - |
dc.contributor.alternativeName | Yang, Joo Young | - |
dc.contributor.alternativeName | Lee, Sang Hak | - |
dc.contributor.alternativeName | Jang, Yang Soo | - |
dc.contributor.alternativeName | Ko, Young Guk | - |
dc.contributor.alternativeName | Kwon, Hyuck Moon | - |
dc.contributor.alternativeName | Kim, B. O. | - |
dc.contributor.affiliatedAuthor | Jeon, Dong Woon | - |
dc.contributor.affiliatedAuthor | Park, S. H. | - |
dc.contributor.affiliatedAuthor | Yang, Joo Young | - |
dc.contributor.affiliatedAuthor | Jang, Yang Soo | - |
dc.contributor.affiliatedAuthor | Ko, Young Guk | - |
dc.contributor.affiliatedAuthor | Kwon, Hyuck Moon | - |
dc.contributor.affiliatedAuthor | Kim, B. O. | - |
dc.contributor.affiliatedAuthor | Lee, Snag Hak | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 104 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 181 | - |
dc.citation.endPage | 185 | - |
dc.identifier.bibliographicCitation | CARDIOLOGY, Vol.104(4) : 181-185, 2005 | - |
dc.identifier.rimsid | 38471 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.